Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia

Amivantamab, the first epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia

Saved in:
Bibliographic Details
Main Authors: Karina J. Cancel-Artau, MD (Author), Angélica C. Marrero-Pérez, MD (Author), Eduardo A. Michelén-Gómez, MD (Author), Xavier Sánchez-Flores, MD (Author)
Format: Book
Published: Elsevier, 2024-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items